Australia markets closed

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.48+0.32 (+3.49%)
At close: 04:00PM EDT
9.77 +0.29 (+3.06%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.05B
Enterprise value 880.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)132.91
Price/book (mrq)4.45
Enterprise value/revenue 128.46
Enterprise value/EBITDA -5.32

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3112.08%
S&P500 52-week change 323.57%
52-week high 312.45
52-week low 33.96
50-day moving average 310.72
200-day moving average 38.00

Share statistics

Avg vol (3-month) 3382.3k
Avg vol (10-day) 3399.13k
Shares outstanding 5111.12M
Implied shares outstanding 6111.12M
Float 849.38M
% held by insiders 12.07%
% held by institutions 174.79%
Shares short (15 Apr 2024) 41.28M
Short ratio (15 Apr 2024) 46.58
Short % of float (15 Apr 2024) 41.74%
Short % of shares outstanding (15 Apr 2024) 41.28%
Shares short (prior month 15 Mar 2024) 41.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-513.32%

Management effectiveness

Return on assets (ttm)-26.61%
Return on equity (ttm)-52.79%

Income statement

Revenue (ttm)6.85M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -170.97M
Net income avi to common (ttm)-151.08M
Diluted EPS (ttm)-1.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)256.55M
Total cash per share (mrq)2.56
Total debt (mrq)85.09M
Total debt/equity (mrq)36.02%
Current ratio (mrq)8.00
Book value per share (mrq)2.39

Cash flow statement

Operating cash flow (ttm)-160.34M
Levered free cash flow (ttm)-97.11M